Ranger Biotechnologies A/S: Financial statements 2020
CVR: 32280404
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,429,278 and a net result of DKK 0 compared with DKK -12,653,117 the year before. That is an increase of 310.8% compared with the year before. Equity in the 2020 report amounted to DKK 717,366. The solvency ratio was 32%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,429,278
- Profit/Loss
- DKK 0
- Equity
- DKK 717,366
- Total Assets
- DKK 2,242,764
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.4M | 0 | 717K | 3 |
| 2019 | - | 591K | -12.7M | 717K | 2 |
| 2018 | - | -832K | -975K | 13.4M | 1 |
| 2017 | - | -1.3M | -4.9M | 14.3M | 1 |
| 2016 | - | 2.1M | 1.5M | 5.9M | 1 |
Official annual report
How creditworthy is Ranger Biotechnologies A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Ranger Biotechnologies A/S has published its annual report for 2019. Gross profit came to DKK 591,403, and the net result was DKK -12,653,117.
About Ranger Biotechnologies A/S
Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.